Neoleukin Therapeutics's activity chart (see below) currently has 29 price targets and 34 ratings on display.
Analysts' price targets on this stock were met 56.52% of the time, taking 286.17 days on average.
Most recent stock forecast was given by from MIZUHO on 09-May-2023. First documented stock forecast 17-Mar-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 15-Nov-2022
$7.5
3 years 6 months 12 days ago
(09-May-2023)
2/2 (100%)
$-10.3 (-57.87%)
371
Hold Since 16-Nov-2022
4 years 5 days ago
(16-Nov-2022)
1/1 (100%)
$-130.4 (-54.24%)
584
Buy Since 06-Jan-2021
$4.5
4 years 6 days ago
(15-Nov-2022)
2/2 (100%)
$-4 (-47.06%)
379
Hold Since 15-Nov-2022
$100
4 years 6 days ago
(15-Nov-2022)
1/1 (100%)
$-122.2 (-55.00%)
643
Buy Since 06-Jul-2022
$20
$200
4 years 6 days ago
(14-Nov-2022)
0/2 (0%)
$11.5 (135.29%)
What is NLTX (Neoleukin Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on NLTX (Neoleukin Therapeutics)?
Which analyst has the most public recommendations on NLTX (Neoleukin Therapeutics)?
Which analyst is the currently most bullish on NLTX (Neoleukin Therapeutics)?
Which analyst is the currently most reserved on NLTX (Neoleukin Therapeutics)?